Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04306952 · ClinicalTrials.gov registry record · NA

Awareness and Self-Compassion Enhancing Narcolepsy Treatment

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT04306952: Completed NA study, sponsored by Northwestern University.

NCT04306952 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04306952, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The overall goal of this research is to test the effectiveness of a mindfulness-based intervention (MBI) for improving health-related quality of life as a complementary practice to standard care for narcolepsy. This study is a feasibility trial in which 60 adults with narcolepsy will be randomized to receive either a 4-week (brief), 8-week (standard), or 12-week (extended) MBI. Each MBI will be delivered in small groups using a live videoconferencing platform and teaches mindfulness practices to help cope with narcolepsy symptoms. By developing a scalable mind-body intervention, this project can addresses a major research gap on improving psychosocial functioning in people with narcolepsy.

Primary Outcome

Number of participants who attended greater than or equal to 80% of sessions

Interventions

  • BEHAVIORAL Brief MBI
  • BEHAVIORAL Standard MBI
  • BEHAVIORAL Extended MBI

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-06-15
Est. Completion 2022-06-30
Phase NA
Northwestern University

1,209 total trials

What the finished NCT04306952 record still lists

NCT04306952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which Brief MBI is the first listed.

NCT04306952 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04306952 about?

NCT04306952 is a clinical study titled "Awareness and Self-Compassion Enhancing Narcolepsy Treatment". The overall goal of this research is to test the effectiveness of a mindfulness-based intervention (MBI) for improving health-related quality of life as a complementary practice to standard care for narcolepsy. This study is a feasibility trial in which 60 adults with narcolepsy will be randomized t...

What is the current status of trial NCT04306952?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-06-15. Estimated completion is 2022-06-30.

What interventions are being tested in trial NCT04306952?

The interventions under investigation include: Brief MBI (BEHAVIORAL), Standard MBI (BEHAVIORAL), Extended MBI (BEHAVIORAL).

Who is sponsoring clinical trial NCT04306952?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04306952's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04306952, the US trial registry maintained by the National Library of Medicine. NCT04306952 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.